Pure Global AI
NCT06410989Not yet recruiting

Evaluation of Sensorimotor Ankle Impairments in Chronic Stroke

Relating Ankle Impairments to Walking Ability for Characterization of Sensorimotor Function in Individuals With Chronic Stroke
Shirley Ryan AbilityLabClinicalTrials.gov
Verified
Study focus
Disease/Condition
Stroke
Study type
Observational
Sponsor & location
Primary sponsor
Shirley Ryan AbilityLab
Location
Chicago, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 20, 2024
End date
Apr 14, 2028
Enrollment
80 participants
Primary outcome

Sensation and voluntary control of the ankle, quantified by spatiotemporal errors during visuomotor tracking and matching tasks using a robotic ankle device

Summary

The purpose of this study is to capture sensorimotor ankle function in a chronic stroke
 population through validation of novel, experimental metrics and their comparison with
 established, clinical measures of function. For this purpose, the researchers will evaluate
 various single-joint, impairment-level measures such as visuomotor tracking performance and
 proprioception as well as functional-level measures including spatiotemporal gait (e.g., gait
 speed and stride length/time) and standardized clinical scales. This study will be carried
 out in chronic stroke patients as well as age-matched healthy controls. Results will help the
 researchers identify more quantitative metrics that can be used to monitor and rehabilitate
 sensorimotor function following stroke.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06410989
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06410989 through Pure Global AI's free database. This phase not specified trial is sponsored by Shirley Ryan AbilityLab and is currently Not yet recruiting. The study focuses on Stroke. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.